angiotensin ii has been researched along with Atrial Remodeling in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 26 (72.22) | 24.3611 |
| 2020's | 10 (27.78) | 2.80 |
| Authors | Studies |
|---|---|
| Demers, J; Ducharme, A; Fiset, C; Huynh, F; Nemer, M; Paradis, P; Thibault, S; Ton, AT | 1 |
| Blanco-Favela, F; Chávez-Sánchez, L; González-Hermosillo, A; Madrid-Miller, A; Martinez-Flores, E; Moreno-Ruiz, LA; Vazquez-González, W; Wacher-Rodarte, N; Zamorano-Velázquez, N | 1 |
| Aonuma, K; Ieda, M; Isoda, H; Li, S; Murakata, Y; Murakoshi, N; Nogami, A; Okabe, Y; Tajiri, K; Tominaga, K; Xu, D; Yuan, Z | 1 |
| Chen, B; Chen, X; Cui, C; Hall, DD; Hong, J; Huang, J; Li, D; Li, F; Lu, M; Pan, Z; Shi, L; Song, L; Song, LS; Wang, B; Wang, J; Wang, Y; Yang, K; Zhang, L; Zhao, S | 1 |
| Gong, X; He, J; Li, Y; Lu, Y; Song, X | 1 |
| Deng, CY; Guo, HM; Li, X; Liu, FZ; Liu, Y; Rao, F; Wang, ZY; Wei, W; Wu, SL; Xue, YM; Yang, H; Zhang, MZ | 1 |
| Okamura, K; Okuda, T; Shirai, K; Takamiya, Y; Urata, H | 1 |
| Brooks, HL; Cannon, DK; Chen, H; Constantopoulos, E; Konhilas, JP; Lipovka, Y; Lopez-Pier, M; McKee, LA; Pollow, D; Regan, JA; Sanchez, JN; Skaria, R | 1 |
| Cha, TJ; Choi, EK; Hajjar, RJ; Jang, SP; Jeong, D; Kook, H; Kwak, TH; Lee, M; Lee, MA; Park, WJ; Raad, N; Song, MH; Yoo, J | 1 |
| An, X; Liu, Y; Liu, YJ; Lv, H; Niu, XH; Tan, R; Xia, YL; Yang, X; Yin, X | 1 |
| Bukowska, A; Corradi, D; Goette, A; Hammwöhner, M; Mahardhika, W | 1 |
| Bach, D; Bode, D; Doerr, R; Guthof, T; Heinzel, FR; Hohendanner, F; Jeuthe, S; Pieske, BM; Primessnig, U; Reimers, S; Wakula, P; Zhang, K | 1 |
| Luo, X; Ma, Q; Wu, Y; Yu, J; Zhang, L; Zhang, Y | 1 |
| Belke, DD; Egom, EE; Jansen, HJ; Kirkby, AW; Mackasey, M; Moghtadaei, M; Rafferty, SA; Rose, RA; Tuomi, JM | 1 |
| Chen, T; Han, J; Huang, W; Jiang, L; Li, J; Liang, G; Wang, J; Wang, Y; Xu, J; Ye, S; Zou, C | 1 |
| Bai, J; Li, HH; Li, J; Lin, QY; Liu, RS; Wang, S; Yu, XH; Zhang, YL | 1 |
| Egom, EE; Jansen, HJ; Kaur, J; Kirkby, AW; Liu, Y; Mackasey, M; Moghtadaei, M; Rafferty, SA; Rose, RA; Tuomi, JM | 1 |
| Berrino, L; Capuano, A; De Angelis, A; Mascolo, A; Rosano, GMC; Rossi, F; Scavone, C; Sessa, M; Urbanek, K | 1 |
| Liu, JJ; Lu, Y; Yu, XJ | 1 |
| Dai, Z; Huang, C; Huang, H; Tang, Y; Wang, X; Xiao, J; Yu, S; Zhao, Q | 1 |
| Gu, J; Guo, M; Liu, F; Liu, X; Song, ZP; Wang, QX; Zhang, DD | 1 |
| Goette, A; Lendeckel, U; Wolke, C | 1 |
| Hong, T; Huanzhang, S; Wenxia, Z; Xijun, X; Yongjun, Q | 1 |
| Chen, K; Chen, Y; Cheng, L; Li, G; Li, J; Liu, E; Liu, T; Wang, X; Yang, W; Zhao, Z | 1 |
| Cartwright, EJ; Chen, S; Christoffels, V; Davies, L; Dong, N; Fraser, JA; Hao, G; Huang, CL; Jin, J; Lei, M; Ravens, U; Shen, W; Shi, Y; Tsui, H; Wang, X; Wang, Y; Wu, J; Zhang, H; Zhang, Y | 1 |
| Huang, JH; Wang, HS; Xue, XD | 1 |
| Apel, IJ; Balogh, A; Binger, KJ; Choi, M; Dechend, R; Fokuhl, V; Haase, N; Henke, N; Heuser, A; Lucas, PC; Luft, FC; Markó, L; McAllister-Lucas, LM; Müller, DN; Oravecz-Wilson, KI; Park, JK; Przybyl, L; Qadri, F; Ruland, J; Spallek, B; Wilck, N | 1 |
| Crowley, SD | 1 |
| Gu, J; Hu, W; Liu, X | 1 |
| Chang, JP; Chang, TH; Chen, MC; Ho, WC; Hsiao, CC; Hsu, SD; Huang, HD; Liu, WH; Wang, FS | 1 |
| Ambrozova, G; Baldus, S; Freeman, BA; Friedrichs, K; Kaur, JJ; Klinke, A; Kubala, L; Martiskova, H; Matthes, B; Mollenhauer, M; Pekarova, M; Ravekes, T; Rudolph, TK; Rudolph, V; Schwoerer, A; Woodcock, SR | 1 |
| Böhm, M; Dhein, S; Hohl, M; Kabiri, M; Linz, D; Reil, JC; Ruf, S; Sadowski, T; Schotten, U; Verheule, S; Wohlfart, P | 1 |
| Bao, M; Cao, Q; Dai, M; Hu, D; Huang, C; Huang, H; Tang, Y; Wang, X; Yu, L; Zhang, Y | 1 |
| Cheng, YJ; Gao, XR; Liu, LJ; Lu, GH; Tang, K; Wu, SH; Xu, CG; Xu, Z; Yao, FJ | 1 |
| Egashira, T; Fukuda, K; Hashimoto, H; Hayashi, K; Hayashiji, N; Ito, S; Kashimura, S; Kodaira, M; Kunitomi, A; Kusumoto, D; Lachmann, M; Motoda, C; Nagai, T; Nakanishi, C; Sakata, K; Seki, T; Shimojima, M; Takei, M; Tohyama, S; Yamagishi, M; Yozu, G; Yuasa, S | 1 |
| Amin, R; Kariharan, T; Nanayakkara, G; Quindry, J; Viswaprakash, N; Zhong, J | 1 |
3 review(s) available for angiotensin ii and Atrial Remodeling
| Article | Year |
|---|---|
Atrial thrombogenesis in atrial fibrillation : Results from atrial fibrillation models and AF-patients.
Topics: Age Factors; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticoagulants; Atrial Appendage; Atrial Fibrillation; Atrial Remodeling; Disease Models, Animal; Endocardium; Heart Atria; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice, Transgenic; Platelet Activation; Risk Assessment; Thromboembolism | 2018 |
Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation?
Topics: Angiotensin I; Angiotensin II; Atrial Fibrillation; Atrial Remodeling; Humans; Peptide Fragments | 2020 |
[Research progress of molecular mechanisms on cardiac remodeling].
Topics: Angiotensin II; Atrial Remodeling; Humans; Phosphatidylinositol 3-Kinases; Signal Transduction; Somatomedins; Transforming Growth Factor beta; Ventricular Remodeling | 2013 |
33 other study(ies) available for angiotensin ii and Atrial Remodeling
| Article | Year |
|---|---|
Atrial Electrical Remodeling in Mice With Cardiac-Specific Overexpression of Angiotensin II Type 1 Receptor.
Topics: Angiotensin II; Animals; Atrial Remodeling; Heart Atria; Mice; Mice, Transgenic; Myocytes, Cardiac; Protein Kinase C-alpha; Receptor, Angiotensin, Type 1 | 2022 |
Post-cardioversion time Course of Atrial Remodeling Markers and their Association with Recurrence in Subjects with Long-standing, Persistent Atrial Fibrillation.
Topics: Aldosterone; Angiotensin II; Atrial Fibrillation; Atrial Remodeling; Biomarkers; Electric Countershock; Humans; Recurrence; Treatment Outcome | 2022 |
Novel preventive effect of isorhamnetin on electrical and structural remodeling in atrial fibrillation.
Topics: Angiotensin II; Animals; Atrial Fibrillation; Atrial Remodeling; Calcium; Heart Atria; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac | 2022 |
CIB2 Is a Novel Endogenous Repressor of Atrial Remodeling.
Topics: Angiotensin II; Animals; Atrial Fibrillation; Atrial Remodeling; Fibrosis; Heart Atria; Mice; RNA | 2023 |
Inhibition of microRNA-146a attenuated heart failure in myocardial infarction rats.
Topics: Angiotensin II; Animals; Animals, Newborn; Antagomirs; Atrial Remodeling; Disease Models, Animal; Heart; Heart Failure; Humans; MicroRNAs; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Rats; Rats, Sprague-Dawley; Ventricular Function, Left; Ventricular Remodeling | 2019 |
High hydrostatic pressure induces atrial electrical remodeling through angiotensin upregulation mediating FAK/Src pathway activation.
Topics: Angiotensin I; Angiotensin II; Animals; Anti-Arrhythmia Agents; Atrial Appendage; Atrial Fibrillation; Atrial Remodeling; Cell Line, Tumor; Focal Adhesion Kinase 1; Humans; Hydrostatic Pressure; Mice; Myocytes, Cardiac; Peptide Fragments; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; src-Family Kinases; Up-Regulation; Valsartan | 2020 |
Elevated chymase-dependent angiotensin II-forming activity in circulating mononuclear leukocytes was observed in the patient of atrial fibrillation.
Topics: Action Potentials; Aged; Aged, 80 and over; Angiotensin II; Atrial Fibrillation; Atrial Remodeling; Biomarkers; Case-Control Studies; Chymases; Cross-Sectional Studies; Female; Heart Rate; Humans; Leukocytes, Mononuclear; Male; Middle Aged | 2020 |
Using 4-vinylcyclohexene diepoxide as a model of menopause for cardiovascular disease.
Topics: Angiotensin II; Animals; Atrial Remodeling; Blood Pressure; Cardiovascular Diseases; Cyclohexenes; Female; Menopause; Mice; Models, Animal; Vinyl Compounds | 2020 |
The matricellular protein CCN5 prevents adverse atrial structural and electrical remodelling.
Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Atrial Remodeling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Line; Cell Transdifferentiation; Dependovirus; Electrophysiological Phenomena; Fibrosis; Heart Atria; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; Myofibroblasts | 2020 |
Platelets Promote Ang II (Angiotensin II)-Induced Atrial Fibrillation by Releasing TGF-β1 (Transforming Growth Factor-β1) and Interacting With Fibroblasts.
Topics: Angiotensin II; Animals; Atrial Fibrillation; Atrial Remodeling; Blood Platelets; Clopidogrel; Fibroblasts; Humans; Hypertension; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Platelet Activation; Platelet Aggregation Inhibitors; Transforming Growth Factor beta1 | 2020 |
Cellular mechanisms of metabolic syndrome-related atrial decompensation in a rat model of HFpEF.
Topics: Angiotensin II; Animals; Atrial Remodeling; Calcium; Calcium Signaling; Cell Nucleus; Cytosol; Disease Models, Animal; Excitation Contraction Coupling; Heart Atria; Heart Failure; Heart Ventricles; Hypertension; Metabolic Syndrome; Myocytes, Cardiac; Rats; Sarcoplasmic Reticulum; Stroke Volume | 2018 |
[Role of ACE2-Ang (1-7)-Mas receptor axis in heart failure with preserved ejection fraction with hypertension].
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Atrial Remodeling; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Heart Failure; Humans; Hypertension; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Stroke Volume; Ventricular Function, Left; Ventricular Remodeling | 2018 |
Distinct patterns of atrial electrical and structural remodeling in angiotensin II mediated atrial fibrillation.
Topics: Action Potentials; Angiotensin II; Animals; Atrial Fibrillation; Atrial Remodeling; Biomarkers; Blood Pressure; Echocardiography; Electrocardiography; Immunohistochemistry; Male; Membrane Potentials; Mice; Myocytes, Cardiac | 2018 |
Angiotensin II Causes Biphasic STAT3 Activation Through TLR4 to Initiate Cardiac Remodeling.
Topics: Angiotensin II; Animals; Atrial Remodeling; Cardiomegaly; Cell Line; Interleukin-6; Mice; Mice, Knockout; Myocytes, Cardiac; Rats; Receptors, Interleukin-6; Signal Transduction; STAT3 Transcription Factor; Toll-Like Receptor 4 | 2018 |
Immunoproteasome Subunit β5i Promotes Ang II (Angiotensin II)-Induced Atrial Fibrillation by Targeting ATRAP (Ang II Type I Receptor-Associated Protein) Degradation in Mice.
Topics: Angiotensin II; Animals; Atrial Fibrillation; Atrial Remodeling; Disease Models, Animal; Fibrosis; Heart Atria; Immunoproteins; Mice; Oxidative Stress; Proteasome Endopeptidase Complex; Receptor, Angiotensin, Type 1 | 2019 |
NPR-C (Natriuretic Peptide Receptor-C) Modulates the Progression of Angiotensin II-Mediated Atrial Fibrillation and Atrial Remodeling in Mice.
Topics: Action Potentials; Angiotensin II; Animals; Atrial Fibrillation; Atrial Remodeling; Disease Models, Animal; Disease Progression; Fibrosis; Heart Atria; Heart Rate; Hypertension; Male; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Receptors, Atrial Natriuretic Factor; Time Factors | 2019 |
Effect of renal sympathetic denervation on atrial substrate remodeling in ambulatory canines with prolonged atrial pacing.
Topics: Aldosterone; Angiotensin II; Animals; Apoptosis; Atrial Fibrillation; Atrial Natriuretic Factor; Atrial Remodeling; Blood Pressure; Cardiac Pacing, Artificial; Dogs; Fibrosis; Gap Junctions; GAP-43 Protein; Heart Atria; Inflammation; Interleukin-6; Kidney; Myocytes, Cardiac; Sympathectomy; Tumor Necrosis Factor-alpha | 2013 |
Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models.
Topics: Angiotensin II; Animals; Atrial Remodeling; Cardiotonic Agents; Cell Proliferation; Cyclic AMP Response Element-Binding Protein; Electrophysiological Phenomena; Fibroblasts; Heart Atria; Ion Channel Gating; Male; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C57BL; Models, Biological; Phosphorylation; Phosphoserine; Pioglitazone; PPAR gamma; Protein Subunits; Receptor, Angiotensin, Type 1; Signal Transduction; Smad Proteins; Thiazolidinediones; TNF Receptor-Associated Factor 6; Transforming Growth Factor beta1 | 2013 |
PPAR-γ activation limits angiotensin II-mediated atrial remodeling: one drug fits all AF patients?
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Atrial Remodeling; Humans; PPAR gamma; Receptor, Angiotensin, Type 1; Thiazolidinediones | 2014 |
From changes in local RAAS to structural remodeling of the left atrium: A beautiful cycle in atrial fibrillation.
Topics: Angiotensin II; Atrial Fibrillation; Atrial Remodeling; Female; Heart Atria; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2015 |
Protective effects of aliskiren on atrial ionic remodeling in a canine model of rapid atrial pacing.
Topics: Amides; Angiotensin II; Animals; Atrial Remodeling; Calcium Channels, L-Type; Cardiac Pacing, Artificial; Dogs; Down-Regulation; Fumarates; Gene Expression; Heart Atria; Hemodynamics; NAV1.5 Voltage-Gated Sodium Channel; Renin; Up-Regulation | 2014 |
Mkk4 is a negative regulator of the transforming growth factor beta 1 signaling associated with atrial remodeling and arrhythmogenesis with age.
Topics: Age Factors; Aged; Angiotensin II; Animals; Atrial Fibrillation; Atrial Remodeling; Case-Control Studies; Cells, Cultured; Computer Simulation; Down-Regulation; Female; Fibrosis; Heart Rate; Humans; Male; MAP Kinase Kinase 4; Mice; Mice, Knockout; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Signal Transduction; Transfection; Transforming Growth Factor beta1 | 2014 |
Angiotensin II activates signal transducers and activators of transcription 3 via Rac1 in the atrial tissue in permanent atrial fibrillation patients with rheumatic heart disease.
Topics: Adult; Aged; Angiotensin II; Atrial Fibrillation; Atrial Remodeling; Female; Fibrosis; Heart Atria; Humans; Male; Middle Aged; Organ Size; rac1 GTP-Binding Protein; Rheumatic Heart Disease; Signal Transduction; STAT3 Transcription Factor | 2015 |
Bcl10 mediates angiotensin II-induced cardiac damage and electrical remodeling.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Atrial Remodeling; B-Cell CLL-Lymphoma 10 Protein; Cell Adhesion; Cell Movement; Cells, Cultured; Disease Models, Animal; Endothelium, Vascular; Fibrosis; Heart Diseases; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Myocardium; NF-kappa B | 2014 |
Linking angiotensin II to nuclear factor-κ light chain enhancer of activated B cells-induced cardiovascular damage: bad CARMAs.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Atrial Remodeling; B-Cell CLL-Lymphoma 10 Protein; Heart Diseases | 2014 |
Pioglitazone improves potassium channel remodeling induced by angiotensin II in atrial myocytes.
Topics: Angiotensin II; Animals; Atrial Remodeling; Cell Line; Electrophysiological Phenomena; Gene Expression Regulation; Heart Atria; Ion Channel Gating; Mice; Myocytes, Cardiac; Pioglitazone; Potassium Channels; Real-Time Polymerase Chain Reaction; RNA, Messenger; Thiazolidinediones | 2014 |
Unraveling regulatory mechanisms of atrial remodeling of mitral regurgitation pigs by gene expression profiling analysis: role of type I angiotensin II receptor antagonist.
Topics: Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atrial Remodeling; Down-Regulation; Female; Gene Expression Profiling; Heart Atria; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Renin-Angiotensin System; Swine; Swine, Miniature; Tetrazoles; Translational Research, Biomedical; Up-Regulation; Valine; Valsartan | 2015 |
Nitrated fatty acids suppress angiotensin II-mediated fibrotic remodelling and atrial fibrillation.
Topics: Action Potentials; Angiotensin II; Animals; Atrial Fibrillation; Atrial Remodeling; Cell Transdifferentiation; Cells, Cultured; Connexin 43; Fibrosis; Heart Atria; Linoleic Acids; Mice; Mice, Inbred C57BL; Nitro Compounds; Smad2 Protein | 2016 |
Cathepsin A mediates susceptibility to atrial tachyarrhythmia and impairment of atrial emptying function in Zucker diabetic fatty rats.
Topics: Action Potentials; Angiotensin II; Animals; Atrial Fibrillation; Atrial Function, Left; Atrial Remodeling; Bradykinin; Cathepsin A; Connexin 43; Diabetes Mellitus, Type 2; Disease Models, Animal; Fibrosis; Heart Rate; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Protease Inhibitors; Rats, Zucker; Time Factors | 2016 |
Low-level carotid baroreflex stimulation suppresses atrial fibrillation by inhibiting left stellate ganglion activity in an acute canine model.
Topics: Angiotensin II; Animals; Atrial Fibrillation; Atrial Remodeling; Baroreflex; Cardiac Pacing, Artificial; Carotid Arteries; Disease Models, Animal; Dogs; Electric Stimulation; Heart Atria; Models, Cardiovascular; Norepinephrine; Stellate Ganglion | 2016 |
The Role of the Rho/ROCK Pathway in Ang II and TGF-β1-Induced Atrial Remodeling.
Topics: Angiotensin II; Animals; Atrial Fibrillation; Atrial Remodeling; Connective Tissue Growth Factor; Disease Models, Animal; Dogs; Female; Male; rho GTP-Binding Proteins; rho-Associated Kinases; Signal Transduction; Transforming Growth Factor beta1 | 2016 |
Emerin plays a crucial role in nuclear invagination and in the nuclear calcium transient.
Topics: Active Transport, Cell Nucleus; Angiotensin II; Aniline Compounds; Animals; Atrial Remodeling; Calcium; Cardiomegaly; Cytoplasm; Disease Models, Animal; Endothelin-1; Fluorescent Dyes; Gene Expression Regulation; Heterocyclic Compounds, 3-Ring; Humans; Membrane Proteins; Muscular Dystrophy, Emery-Dreifuss; Myocardium; Myocytes, Cardiac; Nuclear Envelope; Nuclear Proteins; Phenylephrine; Primary Cell Culture; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Ventricular Remodeling; Xanthenes | 2017 |
PPARγ activation improves the molecular and functional components of I(to) remodeling by angiotensin II.
Topics: Angiotensin II; Animals; Atrial Remodeling; Cardiotonic Agents; Cells, Cultured; Diabetic Cardiomyopathies; Down-Regulation; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Myocytes, Cardiac; Oxidative Stress; Potassium Channels, Voltage-Gated; PPAR gamma; Protein Transport; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Rosiglitazone; Thiazolidinediones; Ventricular Remodeling | 2013 |